Zobrazeno 1 - 10
of 45
pro vyhledávání: '"A. J. Witton"'
Publikováno v:
Education 3-13. :1-14
Autor:
Tove Kirkegaard, Timothy G. Cooke, F M Campbell, Joanne Edwards, John M. S. Bartlett, Linda Boye Jensen, Caroline J Witton, Kirsten Vang Nielsen
Publikováno v:
Histopathology. 56:203-211
Kirkegaard T, Witton C J, Edwards J, Nielsen K V, Jensen L B, Campbell F M, Cooke T G & Bartlett J M S (2010) Histopathology56, 203–211 Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH Aims: The AKT famil
Publikováno v:
British Journal of Cancer
Inactivating PTEN mutations are commonly found in prostate cancer, resulting in an increased activation of Akt. In this study, we investigate the role of PTEN deletion and protein expression in the development of hormone-refractory prostate cancer us
Publikováno v:
Forensic Science International. 167:30-42
This paper reports the results of an investigation to quantify variations in elemental concentrations amongst different particle size fractions obtained from a suite of sediment samples collected from the River Avon, UK. Concentrations of 49 elements
Autor:
Timothy G. Cooke, S. Tovey, John M. S. Bartlett, Caroline J Witton, Amanda Forsyth, Barbara Dunne
Publikováno v:
Clinical Cancer Research. 11:4835-4842
Purpose: Resistance to tamoxifen is linked to overexpression of HER2, and aromatase inhibitors show particular benefit in progesterone receptor (PR)–negative patients. We previously reported reduced survival in patients overexpressing HER1, HER2, a
Autor:
T. G. Cooke, K V Nielsen, T Kirkegaard, L B Jensen, S. Brown, Sven Müller, Caroline J Witton, John M. S. Bartlett, F Campbell
Publikováno v:
Cancer biomarkers : section A of Disease markers. 5(1)
Uncontrolled growth of cancer cells can be related to dysfunctional cell cycle control, including entry into S-phase, initiating cell division. Cyclin CCND3 and CCNE1 along with CDK2 and CDK6 regulate this checkpoint, and genetic changes, detectable
Publikováno v:
Breast Cancer Research
Introduction We have previously linked HER4 expression with increased survival in breast cancer. However, other reports have associated HER4 with adverse prognostic significance. One possible explanation for the conflicting reports may be that these
Autor:
P J Carder, Philippa T. K. Saunders, Valerie Speirs, Peter A. Dervan, John M.S. Bartlett, Amanda McCann, Caroline J Witton, Rosemary A. Walker, M. Kennedy, Abeer M Shaaban, Christopher S. Foster, Claire E Murphy
Publikováno v:
Breast cancer research and treatment. 92(3)
Estrogen receptor (ER) alpha is a well-established independent prognostic factor in breast cancer whose presence determines the clinical implications of adjuvant endocrine therapy. A second receptor, ERb has been described, and a number of studies ha
Autor:
Barbara Dunne, Tove Kirkegaard, Caroline J Witton, John M. S. Bartlett, S. Tovey, Liane M. McGlynn, Alison Lyon
Publikováno v:
The Journal of pathology. 207(2)
Oestrogen receptor (ERalpha) expression is a strong predictor of response to endocrine therapy. The PI3K/AKT/mTOR signal transduction pathway has been implicated in endocrine resistance in vitro. The present study was carried out to test the hypothes
Publikováno v:
Histopathology. 45(1)
Aims: Inflammation and hormonal signalling induce cyclooxygenase 2 (COX2) expression in solid tumours. COX2 expression is linked to neovascularization and tumour growth. HER2 modulates colorectal cancer COX2 expression. We investigated interactions b